WaveMan
WaveMan · Company
OSCR · Oscar Health, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

OSCR Oscar Health (OSCR) Insider Trading, Ownership & Congress Trades

Insurance · Hospital & medical service plans · CIK 0001568651
Quote by TradingView
Form 144 · 12
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
269
13F, latest reported quarter
Conversions, 180 days
6
Codes C/M, not in net · no price filed

What the filings say about OSCR

Insiders, 180 days
-$136.1M net sold
7 sellers · 14% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$52.1M
12 notices

Oscar Health insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Oscar Health, Inc. insiders sold a net $136.1M of stock across 249 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
WITTMAN VANESSA AMES
Director
SELL
2026-09-22 SECtraded 2026-09-18
25,000
$806.0K
+1.5%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 22.3% of the 112,121 shares held after it.
  • 5 other insiders sold within 30 days.
  • 269 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WITTMAN VANESSA AMES sold about $806.0K of OSCR under a 10b5-1 plan on Sep 18, 2026; 5 other insiders sold within 30 days and 269 funds added in the latest 13F quarter.
Baltrus Victoria
Chief Accounting Officer
SELL
2026-09-08 SECtraded 2026-09-03
958
$30.1K
-2.4%
Context
  • 19 earlier Form 4 trades (code P or S) here by this insider (19 sales), the last on Jun 2, 2026.
  • The trade is 0.4% of the 213,631 shares held after it.
  • 5 other insiders sold within 30 days.
  • 269 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Baltrus Victoria sold about $30.1K of OSCR under a 10b5-1 plan on Sep 3, 2026; 5 other insiders sold within 30 days and 269 funds added in the latest 13F quarter.
Blackley Richard Scott
Chief Financial Officer
SELL
2026-09-08 SECtraded 2026-09-03
28,869
$907.9K
-2.4%
Context
  • 37 earlier Form 4 trades (code P or S) here by this insider (37 sales), the last on Aug 18, 2026.
  • The trade is 2.8% of the 1,046,108 shares held after it.
  • 5 other insiders sold within 30 days.
  • 269 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Blackley Richard Scott sold about $907.9K of OSCR under a 10b5-1 plan on Sep 3, 2026; 5 other insiders sold within 30 days and 269 funds added in the latest 13F quarter.
McAnaney Adam
Chief Legal Officer
SELL
2026-09-08 SECtraded 2026-09-03
9,092
$285.9K
-2.4%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Jun 2, 2026.
  • The trade is 4.4% of the 209,004 shares held after it.
  • 5 other insiders sold within 30 days.
  • 269 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer McAnaney Adam sold about $285.9K of OSCR under a 10b5-1 plan on Sep 3, 2026; 5 other insiders sold within 30 days and 269 funds added in the latest 13F quarter.
Schlosser Mario
Director
SELL
2026-09-08 SECtraded 2026-09-03
31,422
$988.2K
-2.4%
Context
  • 38 earlier Form 4 trades (code P or S) here by this insider (1 buy, 37 sales), the last on Aug 28, 2026.
  • The trade is 7.0% of the 449,444 shares held after it.
  • 5 other insiders sold within 30 days.
  • 269 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Schlosser Mario sold about $988.2K of OSCR under a 10b5-1 plan on Sep 3, 2026; 5 other insiders sold within 30 days and 269 funds added in the latest 13F quarter.
249 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 244 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$136.1M over 180 days
-$26.8M over 90 days
below 96% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
269 funds bought in last quarter
more than 70% of Insurance
Revenue
+39.0% year over year
more than 86% of Insurance
Margin
-1549.9% net margin
the lowest in Insurance
Buybacks
no share repurchases reported
Short interest
6.2% of the float short (float per yahoo 2026-10-26) · 2.7 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch OSCR

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+52.1%12M
-47%-8%+30%+68%2025-102025-122026-022026-042026-062026-082026-10 2026-08-27 · Schlosser Mario sold $18.2M2026-06-23 · Schlosser Mario sold $17.5M2026-06-25 · Bertolini Mark T sold $17.1M2026-06-29 · Bertolini Mark T sold $16.2M2026-06-30 · Bertolini Mark T sold $13.9M2026-06-26 · Bertolini Mark T sold $12.8M2026-04-06 · Bertolini Mark T bought $11.9M2026-06-23 · Schlosser Mario sold $8.3M2026-08-28 · Schlosser Mario sold $4.6M2026-06-26 · Bertolini Mark T sold $4.5M2025-11-11 · Schlosser Mario sold $4.4M2026-06-30 · Bertolini Mark T sold $3.9M2026-05-18 · Blackley Richard Scott sold $2.8M2026-05-14 · Blackley Richard Scott sold $2.1M2026-01-02 · Schlosser Mario sold $2.1M2026-06-29 · Bertolini Mark T sold $1.8M2025-11-12 · Schlosser Mario sold $1.6M2026-01-05 · Schlosser Mario sold $1.5M2026-01-06 · Schlosser Mario sold $1.3M2026-06-23 · Schlosser Mario sold $993.7K2026-06-23 · Schlosser Mario sold $993.6K2026-09-03 · Schlosser Mario sold $988.2K2026-07-01 · Schlosser Mario sold $956.7K2026-06-23 · Schlosser Mario sold $944.0K2026-09-03 · Blackley Richard Scott sold $907.9K2026-09-18 · WITTMAN VANESSA AMES sold $806.0K2026-08-18 · Blackley Richard Scott sold $595.1K2025-12-24 · Schlosser Mario sold $582.5K2026-06-02 · Schlosser Mario sold $531.6K2026-06-25 · Bertolini Mark T sold $500.2K2026-06-02 · Blackley Richard Scott sold $493.6K2026-06-23 · Schlosser Mario sold $472.1K2026-06-23 · Schlosser Mario sold $472.1K2026-06-23 · Schlosser Mario sold $448.5K2026-07-01 · Schlosser Mario sold $421.1K2025-12-02 · Blackley Richard Scott sold $417.0K2026-01-08 · Schlosser Mario sold $406.6K2025-12-02 · Schlosser Mario sold $397.6K2026-03-02 · Schlosser Mario sold $325.8K2026-09-03 · Liang Janet sold $325.8K2026-09-03 · McAnaney Adam sold $285.9K2026-03-02 · Blackley Richard Scott sold $257.4K2026-09-18 · WITTMAN VANESSA AMES filed to sell $806.0K2026-09-03 · Blackley Richard Scott filed to sell $908.0K2026-09-03 · Liang Janet filed to sell $325.8K2026-09-03 · McAnaney Adam filed to sell $285.9K2026-09-03 · Schlosser Mario filed to sell $988.2K2026-08-28 · Schlosser Mario filed to sell $4.6M2026-08-27 · Schlosser Mario filed to sell $18.2M2026-08-20 · JEFFERY H. BOYD filed to sell $9.6M2026-08-18 · Richard Scott Blackley filed to sell $614.2K2026-08-13 · JEFFERY H. BOYD filed to sell $8.7M2026-08-10 · JEFFERY H. BOYD filed to sell $3.8M2026-08-10 · BOYD JEFFERY H filed to sell $3.3M2026-06-25 · Mark Bertolini filed to sell $83.1M2026-06-23 · Pizzo-Schlosser Family Dynasty Trust filed to sell $2.7M2026-06-23 · MARIO SCHLOSSER filed to sell $25.1M2026-06-23 · Noah Pizzo-Schlosser Dynasty Trust filed to sell $1.4M2026-06-23 · Siena Pizzo-Schlosser Dynasty Trust filed to sell $1.4M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns OSCR: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
20,587,428 sh
$587.2M
D. E. Shaw & Co., Inc.
12,643,617 sh
$360.6M
VANGUARD PORTFOLIO MANAGEMENT LLC
11,029,424 sh
$314.6M
VANGUARD CAPITAL MANAGEMENT LLC
10,579,437 sh
$301.7M
AMERICAN CENTURY COMPANIES INC
9,055,242 sh
$258.3M

Congress trades in OSCR

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

OSCR planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
WITTMAN VANESSA AMES
Filed 2026-09-18
$806.0K
Blackley Richard Scott
Filed 2026-09-03
$908.0K
Liang Janet
Filed 2026-09-03
$325.8K
McAnaney Adam
Filed 2026-09-03
$285.9K
Schlosser Mario
Filed 2026-09-03
$988.2K

OSCR mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Global X HealthTech ETF
$1.2M position · as of 2026-05-31
4.6%
Towle Value ETF
$7.3M position · as of 2026-05-29
3.6%
CapForce IBD 50 ETF
$2.6M position · as of 2026-07-31
3.2%
Golden Eagle Dynamic Hypergrowth ETF
$2.2M position · as of 2026-06-30
3.1%
RIVER OAK DISCOVERY FUND
$522.2K position · as of 2026-07-31
2.7%
Invesco Dorsey Wright Healthcare Momentum ETF
$4.9M position · as of 2026-07-31
2.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $136.1M sold by insiders over 180 days, 269 funds added last quarter, $52.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
GSHDDGICAPLMRALHCCRVLHGTYKNSLAFLTRVMKLGLTRUP

OSCR financials

Revenue growth
+39.0%
XBRL, annual
Net margin
-1549.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$15.3B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+3.6%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$4.4B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.21x
long-term debt only, 2026-06-30; equity 2026-06-30
Cash flow to debt
10.24x
TTM operating cash flow over long-term debt only, 2026-06-30
Return on equity
+34.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+6.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
invested capital is zero or negative
Return on capital employed
+31.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
23.84x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$11.7B$9.2B$5.9B$4.0B
Operating income-$396.4M$57.3M-$235.6M-$589.9M
Net income-$443.2M$25.4M-$270.7M-$606.3M
EPS (diluted)-1.690.10-1.22-2.85
Operating cash flow$1.1B$978.2M-$272.2M$380.3M
Cash$2.8B$1.5B$1.9B$1.6B
Long-term debt$430.1M$299.6M$298.8M$298.0M
SEC XBRL, fiscal years, as known on 2026-10-27

OSCR Stock Sonar score 6/7 axes

Find similar shapesCompare

OSCR ranks highest on profitability (88th percentile) and growth (86th), and lowest on insider conviction (2nd), among Insurance peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
88
Inputs
  • Return on equity+34.3% · 91 pct, sector of 116
  • Return on assets+6.3% · 78 pct, sector of 122
  • Return on invested capitalinvested capital is zero or negative
  • Return on capital employed+31.1% · 96 pct, universe of 3,236
Financial health
79
Inputs
  • Debt to equity0.21x · 65 pct, sector of 104
  • Cash flow to debt10.24x · 93 pct, sector of 97
Growth
86
Inputs
  • Revenue growth, YoY+39.0% · 86 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
2
Inputs
  • Net Form 4 buying (codes P and S), 180d-$132.8M · 4 pct, sector of 100
  • Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
70
Inputs
  • Funds adding, latest quarter269 · 70 pct, sector of 108
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
13
Inputs
  • Short interest, % of float+6.2% · 21 pct, sector of 138
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+24.0% · 6 pct, sector of 110
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

OSCR filings, in plain words

Are Oscar Health insiders buying or selling OSCR?

In the 180 days to 2026-10-27, Oscar Health insiders were net sellers, a net $136.1M across purchases and sales reported on Form 4, by 7 sellers.

Are there planned insider sales of OSCR?

Yes. 12 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $52.1M of stock; the latest, by WITTMAN VANESSA AMES, was filed 2026-09-18.

Read the full summary

In the 180 days to 2026-10-27, Oscar Health insiders were net sellers of OSCR, a net $136.1M across purchases and sales reported on Form 4 by 7 sellers. 14% of the 44 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 12 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $52.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies